Technology | November 18, 2014

Version three of the software provides greater visibility of subtle lesions and micro-calcifications

November 18, 2014 — ContextVision released GOPView Mammo3, a complete mammography image processing product for both screening and diagnostic imaging.

GOPView Mammo3 provides high transparency of the parenchyma and visibility of subtle lesions and micro-calcifications independent of breast density. This is enabled by the product’s high global and local contrast in combination with intelligent noise suppression.

"As radiologists working at a specialist clinic we need to be able to read mammography images without compromising the accuracy of the diagnosis,” said Jonas Kierkegaard, M.D., and Hans Lundquist, M.D., Bröstcentrum City, Stockholm, Sweden. “The perfect mammogram provides clear micro-calcifications and a transparency of the parenchyma to ensure confidence in finding subtle lesions. A well-balanced, harmonic image helps us in reading mammograms day after day without getting eye fatigue.”

GOPView Mammo3 can be customized according to individual preferences and regional markets.

For more information: www.contextvision.com


Related Content

News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
Subscribe Now